http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106866702-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106866702-B |
| titleOfInvention | The crystal form and preparation method thereof of De Luogewei sodium salt |
| abstract | The present invention relates to the novel crystal forms of De Luogewei sodium salt.Compared to the known crystal form of De Luogewei sodium salt, novel crystal forms of the invention have one or more beneficial properties, such as water stability is good, solubility is high, not easy to moisture absorption, excellent storage stability, granule-morphology are good.The invention further relates to the preparation method of the De Luogewei sodium salt novel crystal forms, its pharmaceutical composition and its it is used to prepare treatment and/or prevents the purposes in the drug that HIV-1 infects. |
| priorityDate | 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.